We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current VRTX market cap is 115.4B. The company's latest EPS is USD 13.8610 and P/E is 32.32.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.48B | 2.57B | 2.69B | 2.65B | 2.77B |
| Operating Income | 1.04B | 988.5M | 1.14B | -3.51B | 1.12B |
| Net Income | 1.04B | 919.6M | 1.1B | -3.59B | 1.05B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.16B | 6.21B | 7.58B | 8.99B | 9.92B |
| Operating Income | 1.2B | 2.86B | 2.78B | 4.31B | 3.83B |
| Net Income | 1.18B | 2.71B | 2.34B | 3.32B | 3.57B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.73B | 22.73B | 23.92B | 20.13B | 22.24B |
| Total Liabilities | 5.21B | 5.15B | 5.37B | 5.36B | 6.61B |
| Total Equity | 16.51B | 17.58B | 18.55B | 14.77B | 15.63B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.32B | 11.75B | 13.43B | 18.15B | 22.73B |
| Total Liabilities | 2.23B | 3.06B | 3.33B | 4.24B | 5.15B |
| Total Equity | 6.09B | 8.69B | 10.1B | 13.91B | 17.58B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 3.3B | 3.54B | 1.31B | -2.45B | -1.08B |
| Investing | -2.26B | -3.14B | -2.14B | -2.6B | -2.95B |
| Financing | -442.4M | -562.2M | -357.5M | -716.1M | -1.1B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.57B | 3.25B | 2.64B | 4.13B | 3.54B |
| Investing | -1.24B | 99.39M | -340.9M | -321.1M | -3.14B |
| Financing | 126.77M | -505.28M | -1.48B | -67.7M | -562.2M |
| Market Cap | 115.4B |
| Price to Earnings Ratio | 32.32 |
| Price to Sales Ratio | 11.63 |
| Price to Cash Ratio | 11.13 |
| Price to Book Ratio | 6.56 |
| Dividend Yield | - |
| Shares Outstanding | 257.59M |
| Average Volume (1 week) | 1.64M |
| Average Volume (1 Month) | 1.27M |
| 52 Week Change | 27.59% |
| 52 Week High | 519.88 |
| 52 Week Low | 346.285 |
| Spread (Intraday) | 2.43 (0.54%) |
| Company Name | Vertex Pharmaceuticals Inc |
| Address |
50 northern avenue boston, massachusetts 02210 |
| Website | https://www.vrtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
